NCT00003822View on ClinicalTrials.gov

SR-45023A in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 31, 1998

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

apomine

Trial Locations (1)

85724

Arizona Cancer Center, Tucson

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00003822 - SR-45023A in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter